Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 121505
Published online Aug 15, 2026. doi: 10.4239/wjd.121505
Published online Aug 15, 2026. doi: 10.4239/wjd.121505
Table 1 Baseline characteristics of study population, n (%)/mean ± SD
| Variable | All patients (n = 312) | No recurrence (n = 184) | Recurrence (n = 128) | Test statistic | P value |
| Age, years | 64.3 ± 10.8 | 63.8 ± 11.2 | 65.1 ± 10.2 | t = 0.98 | 0.328 |
| Male sex | 198 (63.5) | 114 (62.0) | 84 (65.6) | χ2 = 0.42 | 0.517 |
| Diabetes duration, years | 14.0 (10.0-19.0) | 12.0 (9.0-17.0) | 16.0 (12.0-21.0) | Z = 4.12 | < 0.001 |
| Body mass index, kg/m2 | 27.8 ± 4.3 | 27.5 ± 4.1 | 28.2 ± 4.6 | t = 1.35 | 0.178 |
| Current smoking | 87 (27.9) | 42 (22.8) | 45 (35.2) | χ2 = 5.64 | 0.018 |
| Hemoglobin A1c (%) | 7.8 ± 1.4 | 7.3 ± 1.2 | 8.5 ± 1.3 | t = 7.82 | < 0.001 |
| HbA1c ≥ 8.0% | 142 (45.5) | 62 (33.7) | 80 (62.5) | χ2 = 25.3 | < 0.001 |
| Serum albumin, g/L | 36.8 ± 4.2 | 38.2 ± 3.7 | 34.7 ± 4.1 | t = 7.45 | < 0.001 |
| Serum albumin < 35 g/L | 118 (37.8) | 52 (28.3) | 66 (51.6) | χ2 = 17.2 | < 0.001 |
| Peripheral neuropathy score | 6.2 ± 2.1 | 5.4 ± 1.9 | 7.3 ± 1.8 | t = 8.12 | < 0.001 |
| Neuropathy score ≥ 7 | 156 (50.0) | 68 (37.0) | 88 (68.8) | χ2 = 31.5 | < 0.001 |
| Peripheral arterial disease | 164 (52.6) | 74 (40.2) | 90 (70.3) | χ2 = 27.9 | < 0.001 |
| ABI | 0.94 ± 0.21 | 1.02 ± 0.18 | 0.82 ± 0.19 | t = 8.93 | < 0.001 |
| ABI < 0.9 | 147 (47.1) | 58 (31.5) | 89 (69.5) | χ2 = 44.2 | < 0.001 |
| Previous ulcer duration > 8 weeks | 136 (43.6) | 52 (28.3) | 84 (65.6) | χ2 = 43.1 | < 0.001 |
| Inadequate offloading compliance | 143 (45.8) | 56 (30.4) | 87 (68.0) | χ2 = 43.7 | < 0.001 |
Table 2 Univariable Cox proportional hazards regression analysis
| Variable | Hazard ratio (95%CI) | P value |
| Age (per 10-year increase) | 1.08 (0.92-1.27) | 0.342 |
| Male sex | 1.16 (0.79-1.70) | 0.452 |
| Diabetes duration (per 5-year increase) | 1.24 (1.11-1.39) | < 0.001 |
| Current smoking | 1.68 (1.15-2.45) | 0.007 |
| HbA1c ≥ 8.0% | 2.53 (1.74-3.68) | < 0.001 |
| Serum albumin < 35 g/L | 2.18 (1.51-3.14) | < 0.001 |
| Peripheral neuropathy score ≥ 7 | 2.94 (2.02-4.28) | < 0.001 |
| Peripheral arterial disease | 3.21 (2.19-4.70) | < 0.001 |
| ABI < 0.9 | 3.15 (2.16-4.59) | < 0.001 |
| Previous ulcer duration > 8 weeks | 3.68 (2.52-5.37) | < 0.001 |
| Inadequate offloading compliance | 3.42 (2.34-5.00) | < 0.001 |
Table 3 Multivariable Cox proportional hazards regression analysis
| Variable | Hazard ratio (95%CI) | P value |
| Previous ulcer duration > 8 weeks | 3.24 (2.15-4.88) | < 0.001 |
| Peripheral arterial disease | 2.87 (1.92-4.29) | < 0.001 |
| Inadequate offloading compliance | 2.73 (1.82-4.09) | < 0.001 |
| ABI < 0.9 | 2.56 (1.71-3.83) | < 0.001 |
| Peripheral neuropathy score ≥ 7 | 2.45 (1.63-3.68) | < 0.001 |
| HbA1c ≥ 8.0% | 2.18 (1.46-3.25) | < 0.001 |
| Serum albumin < 35 g/L | 1.92 (1.28-2.88) | 0.002 |
Table 4 Model performance metrics
| Metric | Training cohort (n = 218) | Validation cohort (n = 94) |
| C-index (95%CI) | 0.832 (0.789-0.875) | 0.826 (0.787-0.865) |
| Sensitivity at 1 year | 82.3% | 80.6% |
| Specificity at 1 year | 78.9% | 77.4% |
| Positive predictive value | 74.2% | 73.1% |
| Negative predictive value | 85.7% | 84.3% |
| Calibration slope | 0.98 | 0.96 |
| Calibration intercept | 0.02 | 0.04 |
Table 5 Risk stratification groups and recurrence rates
| Risk group | Point range | 1-year recurrence rate | 2-year recurrence rate |
| Low risk | 0-100 | 8.1% (4.2%-12.0%) | 12.3% (7.5%-17.1%) |
| Intermediate risk | 101-180 | 28.4% (22.1%-34.7%) | 38.7% (31.8%-45.6%) |
| High risk | > 180 | 58.9% (51.2%-66.6%) | 71.2% (63.8%-78.6%) |
- Citation: Dai BW, Qi F, Xu GY, Sun W, Tao YN, Ze K. Risk stratification nomogram for diabetic foot ulcer recurrence after healing in type 2 diabetes. World J Diabetes 2026; 17(8): 121505
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/121505.htm
- DOI: https://dx.doi.org/10.4239/wjd.121505